GENE ONLINE|News &
Opinion
Blog

Trials & Approvals
Trials & Approvals Amyotrophic Lateral Sclerosis
Brainstorm’s Stem Cell Therapy Flunks Phase 3 ALS Trial
2020-11-20
Trials & Approvals Non-alcoholic Steatohepatitis
Gilead and Novo Nordisk Present Proof-of-Concept Data for the First Possible NASH Treatment
2020-11-17
Trials & Approvals Influenza
Roche’s Influenza Drug Bags Recommendation for EU Approval
2020-11-15
Trials & Approvals Renal Cell Carcinoma
Merck, Eisai’s Combo Therapy Registers Superiority against Pfizer’s Drug in Kidney Cancer Trial
2020-11-15
Technology PTSD
FDA Allows Marketing of New Device to Reduce Nightmare-Related Sleep Disturbances in Adults
2020-11-13
Trials & Approvals Atopic Dermatitis
Pfizer’s JAK1 Inhibitor Impresses in Phase 3 Atopic Dermatitis Trial
2020-11-12
Trials & Approvals Asthma
Amgen, AstraZeneca’s Tezepelumab Impresses in Phase 3 Asthma Trial
2020-11-11
Trials & Approvals NGS
Foundation Medicine’s Liquid Biopsy Test Bags FDA Approval for Eighth Indication as Companion Diagnostic
2020-11-10
Trials & Approvals Atopic Dermatitis
Pfizer Announces Positive Top-Line Results for JAK Inhibitor in Ankylosing Spondylitis Trial
2020-11-08
Trials & Approvals Alzheimer's Disease
Biogen’s Alzheimer’s Drug Turned Down by Independent Panel
2020-11-07
Trials & Approvals IL-17A
Novartis’ IL-17 Inhibitor Shines in Late-Stage Psoriatic Arthritis Trial
2020-11-06
Trials & Approvals NSCLC
Jounce Discontinues Phase 2 NSCLC Trial After its Combo Therapy with Ipilimubab Folds
2020-11-06
Trials & Approvals Alzheimer's Disease
Biogen Stocks Rise Following FDA’s Inspiriting Comments on Alzheimer’s Drug, Aducanumab
2020-11-05
Trials & Approvals CAR-T Cell
Aiming for the First CAR-T Approval in China, JW Therapeutics Debuts on Hong Kong Stock Exchange
2020-11-04
Trials & Approvals
Bristol Myers Squibb’s Deucravacitinib Impresses in Phase 3 Psoriasis Trial
2020-11-04
1 … 36 37 38 39 40 … 50
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top